165 related articles for article (PubMed ID: 24209894)
1. Longitudinal predictors of uremic pruritus.
Shirazian S; Kline M; Sakhiya V; Schanler M; Moledina D; Patel C; Hazzan A; Fishbane S
J Ren Nutr; 2013 Nov; 23(6):428-31. PubMed ID: 24209894
[TBL] [Abstract][Full Text] [Related]
2. Uremic pruritus and serum phosphorus level.
Gatmiri SM; Mahdavi-Mazdeh M; Lessan-Pezeshki M; Abbasi M
Acta Med Iran; 2013 Aug; 51(7):477-81. PubMed ID: 23945893
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients.
Makhlough A; Emadi N; Sedighi O; Khademloo M; Bicmohamadi AR
Iran J Kidney Dis; 2013 Jan; 7(1):42-6. PubMed ID: 23314141
[TBL] [Abstract][Full Text] [Related]
4. The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial.
Shirazian S; Schanler M; Shastry S; Dwivedi S; Kumar M; Rice K; Miyawaki N; Ghosh S; Fishbane S
J Ren Nutr; 2013 Jul; 23(4):308-14. PubMed ID: 23453391
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Uremic pruritus: roles of parathyroid hormone and substance P.
Cho YL; Liu HN; Huang TP; Tarng DC
J Am Acad Dermatol; 1997 Apr; 36(4):538-43. PubMed ID: 9092738
[TBL] [Abstract][Full Text] [Related]
7. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients.
Noordzij M; Boeschoten EW; Bos WJ; Dekker FW; Bossuyt PM; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2007 Oct; 22(10):2944-9. PubMed ID: 17597087
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus.
Chen YC; Chiu WT; Wu MS
Am J Kidney Dis; 2006 Jul; 48(1):69-76. PubMed ID: 16797388
[TBL] [Abstract][Full Text] [Related]
9. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
Friga V; Linos A; Linos DA
Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
[TBL] [Abstract][Full Text] [Related]
10. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
11. Uremic pruritus. Clinical and experimental studies.
Ståhle-Bäckdahl M
Acta Derm Venereol Suppl (Stockh); 1989; 145():1-38. PubMed ID: 2773616
[TBL] [Abstract][Full Text] [Related]
12. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
13. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
Lucchi L; Carboni C; Stipo L; Malaguti V; Ferrari F; Graziani R; Arletti S; Graziosi C
Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793
[TBL] [Abstract][Full Text] [Related]
14. Association between pruritus and serum concentrations of parathormone, calcium and phosphorus in hemodialysis patients.
Tajbakhsh R; Joshaghani HR; Bayzayi F; Haddad M; Qorbani M
Saudi J Kidney Dis Transpl; 2013 Jul; 24(4):702-6. PubMed ID: 23816717
[TBL] [Abstract][Full Text] [Related]
15. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled clinical trial comparing the efficacy of dead sea mineral-enriched body lotion versus two types of placebo in the treatment of cutaneous dryness, itching, peeling and tightness in hemodialysis patients (EDIT).
Boaz M; Shtendik L; Oron M; Portugal-Cohen M; Kohen R; Biro A; Cernes R; Barnea Z; Maor Z; Katzir Z
Nephron Clin Pract; 2009; 113(3):c169-76. PubMed ID: 19672115
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate.
Chertow GM; Blumenthal S; Turner S; Roppolo M; Stern L; Chi EM; Reed J;
Clin J Am Soc Nephrol; 2006 Mar; 1(2):305-12. PubMed ID: 17699221
[TBL] [Abstract][Full Text] [Related]
18. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy.
Blachley JD; Blankenship DM; Menter A; Parker TF; Knochel JP
Am J Kidney Dis; 1985 May; 5(5):237-41. PubMed ID: 4003393
[TBL] [Abstract][Full Text] [Related]
19. Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: A cross-sectional study.
Zhao JH; Zhu QS; Li YW; Wang LL
PLoS One; 2021; 16(1):e0245370. PubMed ID: 33471852
[TBL] [Abstract][Full Text] [Related]
20. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
